Pasadena, CA, United States of America

Alphonsus Hon-Chung Ng


Average Co-Inventor Count = 4.2

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Alphonsus Hon-Chung Ng

Introduction

Alphonsus Hon-Chung Ng is a notable inventor based in Pasadena, CA. He has made significant contributions to the field of immunology, particularly in the identification and purification of antigen-specific T cells. With a total of 2 patents, his work has implications for cancer therapy and immunological research.

Latest Patents

Ng's latest patents include groundbreaking methods and devices for identifying antigen-specific T cells. One patent focuses on pairing antigen specificity of a T cell with T cell receptor sequences. This includes compositions and methods for identifying antigen-specific T cells, as well as determining paired T cell receptor sequences for specific antigens. Another patent describes microfluidic devices that are useful for identifying antigen-specific T cells and methods for purifying rare antigen-specific T cell populations. These innovations enable the separation and isolation of barcoded T cells from other nanoparticles for further analysis and processing.

Career Highlights

Throughout his career, Ng has worked with prestigious institutions such as the California Institute of Technology and the Gwangju Institute of Science and Technology. His research has contributed to advancements in understanding T cell behavior and enhancing therapeutic strategies.

Collaborations

Ng has collaborated with esteemed colleagues, including James R. Heath and Songming Peng. Their combined expertise has furthered the development of innovative solutions in the field of immunology.

Conclusion

Alphonsus Hon-Chung Ng's contributions to the field of immunology through his patents and collaborations highlight his role as a significant inventor. His work continues to influence research and therapeutic approaches in identifying and utilizing T cells for medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…